PHASE-II TRIAL OF DICHLOROMETHOTREXATE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

被引：0
|
作者：
ROBERTS, JA
BLESSING, JA
MCGEHEE, R
BEECHAM, J
HOMESLEY, HD
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DIV GYNECOL ONCOL,JACKSON,MS 39216
[3] UNIV ROCHESTER,MED CTR,DIV GYNECOL ONCOL,ROCHESTER,NY 14642
[4] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT OBSTET & GYNECOL,WINSTON SALEM,NC 27103
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1295 / 1296
页数：2
相关论文
共 50 条
  • [21] PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    STEHMAN, FB
    MALFETANO, J
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1127 - 1128
  • [22] PALA (NSC-224131) IN ADVANCED-CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    BUNDY, B
    DISAIA, PJ
    STEHMAN, FB
    BEECHAM, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06): : 741 - 744
  • [23] A PHASE-II TRIAL OF GALLIUM NITRATE (NSC-15200) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MALFETANO, JH
    BLESSING, JA
    HOMESLEY, HD
    HANJANI, P
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 109 - 111
  • [24] PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN ADVANCED OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SUTTON, GP
    BLESSING, JA
    HOMESLEY, HD
    BERMAN, ML
    MALFETANO, J
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) : 1672 - 1676
  • [25] PHASE-II TRIAL OF PIPERAZINEDIONE IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    PETTY, W
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 21 - 23
  • [26] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    DELGADO, G
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1669 - 1671
  • [27] A PHASE-II TRIAL OF LEUPROLIDE ACETATE IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MILLER, DS
    BRADY, MF
    BARRETT, RJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (02): : 125 - 128
  • [28] PHASE-II TRIAL OF VP-16-213 IN THE TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE OVARY - GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    CREASMAN, WT
    PETTY, W
    BUNDY, B
    BLESSING, JA
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2089 - 2092
  • [29] PHASE-II TRIAL OF PIPERAZINEDIONE IN PATIENTS WITH ADVANCED OR RECURRENT UTERINE SARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    HACKER, N
    CURRY, SL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05): : 350 - 352
  • [30] MITOXANTRONE IN THE TREATMENT OF ADVANCED NON-SQUAMOUS CARCINOMA OF THE CERVIX (A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP)
    MUSS, HB
    BUNDY, BN
    HOMESLEY, HD
    WILBANKS, G
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (02) : 199 - 202
12345